"We expect the MD Anderson Cancer Center Orlando to be the model for additional proton centers we are developing." I think that sentence and the one just prior, which stated the financing was similar to that they had used for gamma knifes which would imply basically standard bank financing with little dilution are extremely meaningful. Just on what they have announced already with additional units at Tufts, Long Beach and two rooms at Kettering this would imply an ebitda potential that far exceeds the current market cap. That includes nothing for future contracts which one would think may be in discussions since fda approval as all their currently announced deals were prior. It is going to be interesting to watch this stock when the world puts all this together.